Cargando…
LBA76_PR Expected medium and long term impact of the COVID-19 outbreak in oncology
Autores principales: | Jerusalem, G., Onesti, C.E., Generali, D.G., Harbeck, N., Wildiers, H., Curigliano, G., Campone, M., Tjan-Heijnen, V., Martin, M., Cristofanilli, M., Pusztai, L., Bartsch, R., Peeters, M., Berchem, G., Tagliamento, M., Cortés, J., Ruhstaller, T., Ciruelos, E.M., Rottey, S., Rugo, H.S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506324/ http://dx.doi.org/10.1016/j.annonc.2020.08.2317 |
Ejemplares similares
-
Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology
por: Onesti, Concetta Elisa, et al.
Publicado: (2021) -
Oncological care organisation during COVID-19 outbreak
por: Onesti, Concetta Elisa, et al.
Publicado: (2020) -
LBA77 Anti-SARS-CoV-2 antibody response in patients with cancer and oncology healthcare workers: A multicenter, prospective study
por: Marra, A., et al.
Publicado: (2020) -
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer
por: Schettini, Francesco, et al.
Publicado: (2021) -
LBA81 Keeping exhausted T-cells in check in COVID-19
por: Van Mol, P., et al.
Publicado: (2020)